Closo-carboranyl- and metallacarboranyl [1,2,3]triazolyl-decorated lapatinib-scaffold for cancer therapy combining tyrosine kinase inhibition and boron neutron capture therapy
One of the driving forces of carcinogenesis in humans is the aberrant activation of receptors; consequently, one of the most promising mechanisms for cancer treatment is receptor inhibition by chemotherapy. Although a variety of cancers are initially susceptible to chemotherapy, they eventually deve...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , , , , |
| Format: | article |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12008/32294 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Closo-carboranyl- and metallacarboranyl [1,2,3]triazolyl-decorated lapatinib-scaffold for cancer therapy combining tyrosine kinase inhibition and boron neutron capture therapy
- Advancements in the synthesis and biological properties of carboranes and high‑boron related compounds: a comprehensive exploration with emphasis on BNCT applications
- Diseño, síntesis y evaluación biológica de nuevos organoboranos con uso en terapia antitumoral de glioblastoma por captura neutrónica de boro (10B)
- The role of radiation therapy in management parotid cancer therapy
- About pathology and biliary therapy
- Radiation therapy for gastric cancer
- Lung cancer radiation therapy